Back

Characterization of a heterogenous activated B cell compartment arising early after antigen exposure preceding long-lived memory B cell formation

Fernandez Blanco, L.; Kuijper, L. H.; Kummer, L. Y.; Verstegen, N. J.; Bos, A.; Claireaux, M.; Duurland, M. C.; Jorritsma, T.; Steenhuis, M.; Kerster, G.; Garcia-Vallejo, J. J.; van Gils, M. J.; van Dam, K. P.; Stalman, E. W.; Wieske, L.; Boekel, L.; Wolbink, G.; Tas, S. W.; Rispens, T.; Kuijpers, T. W.; Eftimov, F.; ten Brinke, A.; van Ham, S. M.; On behalf of T2B! Immunity against SARS-CoV-2 study group,

2024-12-23 immunology
10.1101/2024.12.22.629610 bioRxiv
Show abstract

Once formed, plasma cells and memory B cells (MBCs) are difficult to eradicate, posing a problem in the context of unwanted antibody responses. Characterizing early B cell differentiation stages after antigen encounter is thus crucial to target and prevent unwanted antibody formation. Here, we unravelled in-depth antigen-specific B cell responses longitudinally after SARS-CoV-2 mRNA vaccination in healthy individuals using multiparameter spectral flow cytometry. The early antigen-specific B cell response was dominated by spike-specific IgG+ CD27+ CD71+ activated B cells (ActBCs), previously assigned as germinal center-derived and DN2 extrafollicular B cells. Within the early IgG+ ActBC compartment, six distinct clusters were identified with specific contraction dynamics, whereby some of these clusters were more closely related to pre-ASCs and others more to long-lived MBCs. Some of the highly contracting ActBC clusters expressed CD11c, a marker previously used to define atypical B cells. The transient presence of different ActBC clusters could also be observed in total B cells when gated in an antigen- independent manner. Our results thus delineate the early stages of the antigen-specific B cell response, with a further dissection of the CD71+ ActBC compartment. Detection of ActBC clusters early after antigen encounter in total B cells opens avenues for future evaluation of their potential to serve as a proxy for antigen-reactive B cells in autoimmunity or other unwanted B cell responses.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.